The estimated Net Worth of Healthcare Holdings, Llcfar... is at least 4.68 百万$ dollars as of 16 June 2020. Healthcare Llcfar owns over 400,000 units of Generation Bio Co stock worth over 4,681,918$ and over the last 4 years Healthcare sold GBIO stock worth over 0$.
Healthcare has made over 1 trades of the Generation Bio Co stock since 2020, according to the Form 4 filled with the SEC. Most recently Healthcare bought 400,000 units of GBIO stock worth 7,600,000$ on 16 June 2020.
The largest trade Healthcare's ever made was buying 400,000 units of Generation Bio Co stock on 16 June 2020 worth over 7,600,000$. On average, Healthcare trades about 400,000 units every 0 days since 2020. As of 16 June 2020 Healthcare still owns at least 1,918,819 units of Generation Bio Co stock.
You can see the complete history of Healthcare Llcfar stock trades at the bottom of the page.
Over the last 4 years, insiders at Generation Bio Co have traded over 37,722,950$ worth of Generation Bio Co stock and bought 4,282,125 units worth 70,408,633$ . The most active insiders traders include Jason P Rhodes、Biomedical Innovation Maste...、Public Equities, L.P.Minne .... On average, Generation Bio Co executives and independent directors trade stock every 11 days with the average trade being worth of 116,471$. The most recent stock trade was executed by Yalonda Howze on 15 July 2024, trading 3,347 units of GBIO stock currently worth 8,167$.
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Generation Bio Co executives and other stock owners filed with the SEC include: